Janae L. Stovall

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

Jorge E. Osorio, Iván Darío Vélez, Cynthia A. Thomson et al. · The Lancet Infectious Diseases · 2014 · 149 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +9

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

Sarah L. George, Mimi Wong, Tina Dube et al. · The Journal of Infectious Diseases · 2015 · 86 citations · Full text

Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)

Claire Y.‐H. Huang, Richard M. Kinney, Jill A. Livengood et al. · PLoS neglected tropical diseases · 2013 · 70 citations · Full text

O'nyong nyong Virus Molecular Determinants of Unique Vector Specificity Reside in Non-Structural Protein 3

Kali D. Saxton-Shaw, Jeremy P. Ledermann, Erin M. Borland et al. · PLoS neglected tropical diseases · 2013 · 66 citations · Full text

Genetics, Malaria, Molecular Biology +19

Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion

John T. Roehrig, Siritorn Butrapet, Nathan M. Liss et al. · Virology · 2013 · 48 citations

Virus Structure, Viral Replication, Pathogenesis +10